Commitment COM-213
Post-approval commitment for CDSCO-2022-0013. Category: REMS. Priority: high.
Commitment ID
COM-213
Application
Authority
Central Drugs Standard Control Organisation
Category
REMS
Priority
high
Status
Open
Due Date
2024-11-30
Completed At
—
Owner
Marcus Webb
Created
2022-11-24
Description
Complete Phase IV post-marketing observational study (n=500)
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.